Form D · Other Health Care
ROM Technologies, Inc.
Brookfield, CT · CIK 0001600001
Offering snapshot reported Feb 19, 2026 · SEC filing
- Reported sold
- $448M Indefinite offering
- Investors reported
- 3,556 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Sep 15, 2014 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$0 → $448,056,161
- Reported investors926 → 3,556
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 19, 2026 | Amendment | $448,056,161 | $448,056,161vs Sep 2, 2025 | 3,556 | SEC filing |
| Sep 2, 2025 | Amendment | $0 | No comparison | 926 | SEC filing |
| Jul 30, 2025 | Amendment | $1,415,000 | $0vs Jul 24, 2025 | 174 | SEC filing |
| Jul 30, 2025 | Amendment | $900,000 | $0vs Jul 24, 2025 | 18 | SEC filing |
| Jul 29, 2025 | Amendment | $0 | No comparison | 1,128 | SEC filing |
| Jul 29, 2025 | Amendment | $50,000 | $0vs Mar 4, 2022 | 1 | SEC filing |
| Jul 29, 2025 | Amendment | $45,389,296 | $0vs Jul 25, 2025 | 1,133 | SEC filing |
| Jul 29, 2025 | Amendment | $0 | No comparison | 914 | SEC filing |
| Jul 29, 2025 | Amendment | $0 | No comparison | 874 | SEC filing |
| Jul 29, 2025 | Amendment | $0 | No comparison | 477 | SEC filing |
| Jul 29, 2025 | Amendment | $200,000 | $0vs Jan 25, 2024 | 446 | SEC filing |
| Jul 29, 2025 | Amendment | $200,000 | $0vs Jan 25, 2024 | 63 | SEC filing |
| Jul 29, 2025 | Amendment | $0 | No comparison | 809 | SEC filing |
| Jul 29, 2025 | Amendment | $1,050,000 | $0vs Sep 3, 2021 | 14 | SEC filing |
| Jul 25, 2025 | Amendment | $45,389,296 | $45,339,296vs Mar 4, 2022 | 1,133 | SEC filing |
| Jul 25, 2025 | Amendment | $49,160,296 | $48,959,296vs Apr 26, 2022 | 1,206 | SEC filing |
| Jul 25, 2025 | Amendment | $56,725,613 | $56,625,613vs Aug 29, 2022 | 1,348 | SEC filing |
| Jul 25, 2025 | Amendment | $75,517,345 | No comparison | 1,689 | SEC filing |
| Jul 25, 2025 | Amendment | $77,567,874 | No comparison | 1,720 | SEC filing |
| Jul 25, 2025 | Amendment | $80,687,524 | No comparison | 1,766 | SEC filing |
| Jul 25, 2025 | Amendment | $41,541,274 | $40,441,274vs Jan 24, 2022 | 1,062 | SEC filing |
| Jul 25, 2025 | Amendment | $37,225,337 | $37,191,837vs Nov 22, 2021 | 985 | SEC filing |
| Jul 24, 2025 | Amendment | $900,000 | No comparison | 18 | SEC filing |
| Jul 24, 2025 | Amendment | $665,000 | $0vs Dec 26, 2018 | 18 | SEC filing |
| Jul 24, 2025 | Amendment | $570,000 | $0vs Sep 28, 2018 | 10 | SEC filing |
| Jul 24, 2025 | Amendment | $500,000 | $0vs Feb 13, 2018 | 22 | SEC filing |
| Jul 24, 2025 | Amendment | $35,000 | $0vs Jul 28, 2016 | 1 | SEC filing |
| Jul 24, 2025 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Jul 24, 2025 | Amendment | $1,415,000 | $1,340,000vs May 4, 2020 | 174 | SEC filing |
| Jul 24, 2025 | Amendment | $20,865,019 | $20,840,019vs Feb 2, 2021 | 631 | SEC filing |
| Jul 24, 2025 | Amendment | $27,191,113 | $27,116,113vs May 20, 2021 | 767 | SEC filing |
| Jul 24, 2025 | Amendment | $32,079,680 | $29,989,680vs Aug 11, 2021 | 867 | SEC filing |
| Jul 21, 2025 | Amendment | $35,000 | $0vs Apr 14, 2016 | 1 | SEC filing |
| Jul 21, 2025 | Amendment | $25,000 | $0vs Sep 15, 2015 | 1 | SEC filing |
| Nov 29, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Nov 15, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 7, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 24, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 25, 2024 | Initial | $200,000 | No comparison | 5 | SEC filing |
| Dec 29, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 18, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Mar 2, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 31, 2023 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Jan 13, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Aug 29, 2022 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Apr 26, 2022 | Initial | $375,000 | No comparison | 8 | SEC filing |
| Apr 26, 2022 | Initial | $201,000 | No comparison | 6 | SEC filing |
| Mar 4, 2022 | Amendment | $50,000 | $0vs Nov 22, 2021 | 1 | SEC filing |
| Jan 24, 2022 | Initial | $1,100,000 | No comparison | 1 | SEC filing |
| Nov 22, 2021 | Initial | $33,500 | No comparison | 1 | SEC filing |
| Nov 22, 2021 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Sep 3, 2021 | Initial | $1,050,000 | No comparison | Not reported | SEC filing |
| Aug 11, 2021 | Initial | $2,090,000 | No comparison | 42 | SEC filing |
| May 20, 2021 | Amendment | $0 | No comparison | 0 | SEC filing |
| May 20, 2021 | Amendment | $25,000 | No comparison | Not reported | SEC filing |
| May 20, 2021 | Amendment | $75,000 | No comparison | Not reported | SEC filing |
| Feb 2, 2021 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Dec 31, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 4, 2020 | Initial | $75,000 | No comparison | 2 | SEC filing |
| Jul 22, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 26, 2018 | Initial | $665,000 | No comparison | 18 | SEC filing |
| Sep 28, 2018 | Initial | $570,000 | No comparison | 10 | SEC filing |
| Feb 13, 2018 | Initial | $500,000 | No comparison | 22 | SEC filing |
| Jun 27, 2017 | Initial | $185,000 | No comparison | 4 | SEC filing |
| Jul 28, 2016 | Amendment | $35,000 | $0vs Apr 14, 2016 | 1 | SEC filing |
| Apr 14, 2016 | Initial | $35,000 | No comparison | 1 | SEC filing |
| Sep 15, 2015 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Jul 10, 2014 | Initial | $30,000 | No comparison | 2 | SEC filing |
| Feb 14, 2014 | Initial | $60,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-530742
Source: Form D, filed Feb 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Arn | Director, Executive |
| Michael Bissonnette | Director |
| Edwin Dearborn | Director |
| Robert Grant Edwards | Executive |
| Scott Freedman | Executive |
| Sanford Gomberg | Director, Executive |
| Mike Holston | Executive |
| Gordon Hull | Executive |
| Kenneth Wayne Johnson | Director, Executive, Promoter |
| Charles Parker | Executive |
| Gomberg A Sanford | Director, Executive |
| Steve Seger | Executive |
| Steve Siegel | Executive |
| Alan Tucker | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
101 Silvermine Rd.
Brookfield, CT, 06804
Brookfield, CT, 06804